Oro Health, a Montreal, Canada-based virtual health care company, raised $3m in seed financing.
The mix of capital and loans came from a range of private investors including Canadian MCI Onehealth, the private group of investors TGIC2 and Desjardins Capital.
The funds will enable the company to accelerate development of its platform and business model.
Founded in 2020, Oro Health is a leader in the creation of asynchronous telemedicine solutions for health professionals who wish to optimize patient access and care. Its founders Dr. Émilie Bourgeault and Dr. Marc-André Doré, who are both certified dermatologists, and business analyst Jean-Philippe Doré, have dedicated themselves to putting advanced technologies such as artificial intelligence at the service of Canadian medical clinics and patients.
The artificial intelligence powered technology developed by ORO Health, will provide patients across the country with access to medical professionals as well as the ability to obtain rapid and secure care, at any time, at homes.
ORO Health emerged alongside DermaGO, Canada’s first private dermatology telemedicine clinic, which was founded in 2018 by Dr. Bourgeault, and her two partners, Dr. Marc-André Doré, a dermatologist, and Jean-Philippe Doré, a business analyst. During its first two years in operation, DermaGO enabled 10,000 Canadian patients to obtain a diagnosis from a certified dermatologist for minor skin conditions in just a few hours, without the need for a prior referral from a general practitioner.